Original Research Article
DOI: https://dx.doi.org/10.18203/issn.2454-5929.ijohns20221644
Factors involved in diagnosis delay and poor prognosis in laryngeal squamous carcinoma: a retrospective study about 86 cases
1Faculty of Medicine and Pharmacy of Agadir, Ibn Zohr University, Agadir, Morocco
2Faculty of Medicine and Pharmacy of Marrakech, Cadi Ayyad University, Marrakech, Morocco
Received: 15 April 2022
Revised: 11 June 2022
Accepted: 13 June 2022
*Correspondence:
Dr. Sara Rochd,
E-mail: Sara.rochd@gmail.com
Copyright: © the author(s), publisher and licensee Medip Academy. This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
ABSTRACT
Background: Squamous cell carcinoma of head and neck seems to be the seventh most common histological type worldwide with a great morbidity and mortality rates. Multiple published papers studied the overall survival of laryngeal squamous carcinoma depending on different factors. The aim of the study was to analyze the different factors that could impact the patient and the professional delays, and hence analyze factors related to poor prognosis and overall survival rates.
Methods: Retrospective descriptive and analytic study between January 2015 and January 2020 in ENT-HNS department in university hospital Mohammed VI of Marrakech. All patients admitted for confirmed histologically with a primary laryngeal squamous carcinoma and who consented to this study were included in our study, grouping 86 patients.
Results: Age and denial of care were the factors related to patient delay (p=0.044), medical doctors (0.030), the first consult decision (0.044) and the malpractice (0.008) were statistically related to the professional delay. The multivariate analysis with disease specific survival found that the tumor location (p=0.022), the disease staging at diagnosis (0.047), the Charlson comorbidity index (p=0.017), the patient delay and professional delay (p<0.001) were associated to a poor survival rate.
Conclusions: Patient and professional delays are factors that could be controlled by emphasizing the importance of medical consult when presenting laryngeal symptoms and the essential role of primary care doctors during 1st consult and how crucial it is to make a full examination and even refer patients to specialist when malignancy is suspected.
Keywords: Laryngeal squamous carcinoma, Delay in laryngeal carcinoma, Dysphonia
INTRODUCTION
Laryngeal cancer comes in the second place in all head and neck cancers and the squamous cell carcinoma of head and neck seems to be the seventh most common histological type worldwide.1,2
Nevertheless, this type of malignant tumors is often diagnosed in its advanced, aggressive stages, which leads to a great morbidity and mortality rates; as the clinical staging is directly related to a poor prognosis.3-5
This problematic has been the subject of multiple papers; studying the overall survival of laryngeal squamous carcinoma.1-6 So, what are the incriminated factors leading to this delayed diagnosis and in consequence poor prognosis? What are the reasons behind patient and professional delay?
The objective of this study is to analyse the different factors that could impact the patient and the professional delays, and hence analyze factors related to poor prognosis and overall survival rates.
METHODS
We conducted a retrospective descriptive and analytic study between January 2015 and January 2020 in the ENT-HNS department in university hospital Mohammed VI of Marrakech.
We used a non-probability sampling method: Purposive sampling. The inclusion criteria were mainly based on a histologically confirmation of a primary laryngeal squamous carcinoma, to which no exclusion criteria were needed; we thus collected data from 86 patients.
Patient delay was defined by the time gap between the date of the constatation of the first symptom and the date of the first consult.
Professional delay was defined by the time gape between the date of the first consultation and the date of the diagnosis assessment.
Total delay was defined by the sum of both patient and professional delay. The delay is presented in weeks.
Charlson comorbidity index was used to categorize the patient status and we defined subgroups as follow: No comorbidity; CI score 0; Modest comorbidity; CI score 1-2; High comorbidity; CI score; 3 or more.
The statistical study was conducted using SPSS, all variable were categorized in groups.
We compared the groups using the Kruskal-Wallis tests.
The survival functions were determined using Kaplan-Meier method and compared using Breslow’s test. The multivariate analysis used cox regression with disease-specific survival from the survival status at the time the study was conducted.
RESULTS
Epidemiological findings
Our studied population was mostly composed of male elderly as the mean age was 62.03 (45-86), with 95.3% males. Socioeconomical level was defined based on our country’s social norms and 91.9% of our patients have a low socioeconomic level. We studied different variables that might be involved in the patient delay such as transportation cost and the distance to the nearest health facility and the most found reasons for patients delay were lack of means, denial of care and the use of traditional treatments.
Although all these factors can impact the extension of delays but the only two variables with a statistically significant difference found with the age (p=0.044) and the denial of care (p=0.042). Table 1 regroups the results of the statistical study. Figure 1 are plots of the statistical difference.
Patients’ presentation
The 91.9% of our patients were smokers and drinkers. The comorbidity status evaluated by Charlson comorbidity index and categorized in subgroups found 69.8% of patients with modest comorbidity, 29.1% with high comorbidity and 1.2% with no comorbidity. General medical doctors’ opinion was sought in 75.6% of cases, the 24.4% others went directly to a specialist. The major symptom found in patients was hoarseness in 95.3% other symptoms as pharyngalgia, neck lumps and dyspnea were less found in our series. The medical conduct was using medical treatment in 65.1%, to refer to a specialist in 11.6% cases and to undergo an endoscopic examination and a biopsy in 23.3% cases. There was a difference statistically significant with the professional delay and the medical doctor firstly consulted (p=0.030), the medical conduct in the first consult (p=0.044) and the mismanagement (p=0.008). Table 2 regroups results of statistical study (Figure 2).
Diagnosis delay
The mean total delay in weeks was 76.36, with a minimum and maximum delay 9 and 373 weeks.
The mean patient and professional delay were respectively 61.49 (6-343) and 14.81 (1-84) weeks (Table 3).
The mean of patient delay was 61.49 weeks. and thought there was a difference between different groups of patients, the latest was not statistically significant. Same goes for the professional delay where the mean delay was 14.81 weeks.
Diagnosis delay and survival
The patients aged 65 or more, smokers and drinkers were not related to over-all survival as shown respectively in Figure 3.
The comparison showed a meaningful statistical relationship between the number of comorbidity and the disease staging at diagnosis with the overall survival (Figure 4).
The multivariate analysis showed that the glottic tumor location (p=0.022), the stage IV of the disease (p=0.047) the high comorbidity (p=0.017) and the patient and the professional delay (p<0.001) are strongly associated with poor prognosis and the overall survival. The cox regression analysis results are presented in Table 4 and the graphical presentation of the equation is presented in Figure 5.
*Statically significant p<0.05.
*Statically significant p<0.05.
*Statically significant p<0.05.
DISCUSSION
Squamous cell carcinoma of head and neck seems to be the seventh most common histological type worldwide with a great morbidity and mortality rates.6 Laryngeal cancer as a subgroup account for 13360 cancer diagnosis and 3660 in the United States in 2017, This show the importance of the study of factors that may be impactful to reduce the mortality and also the quality of life in these patients, with an early diagnosis assessment and treatment start.7
Multiple published papers studied the overall survival of laryngeal squamous carcinoma depending on different factors. Our delays were much more extended, exceeding two years in some cases, than the ones reported in the literature this could be explained by difference of cultural and infrastructure difference between countries.5-10
Though there was no statistically significant relation between the patients socioeconomical level and the poor access to health care facilities in our study with patients delay, but Kompelli and al, and Ramos and al explained that population with poorer income and access to health care were associated with decreased hazard.7,11
The diagnosis of laryngeal tumor is in the end made by the consultant and chronic hoarseness is known to be the first symptom to make the practician suspect a laryngeal tumor and even malignancy, in the other hand patients tend to neglect it and this of it as a benign affection that ’s going to resolve spontaneously.4,8,12 Conversely, when patients take their symptoms seriously and seek medical advice, their condition could be mislabelled.8
Schwartz and al published in 2009 clinical practice guideline for hoarseness and considered it an option to perform a laryngeal mirror examination or a laryngoscopy, reversing it smith and al find that the balance benefice risk tends to make it a recommendation or a strong recommendation to perform a laryngoscopy or refer for a laryngoscopy.13,14
In our case primary care doctors first choice was to treat patient they received for chronic dysphonia as a benign infection or as an acute laryngitis, instead of suspecting malignancy and referring the patient for a laryngoscopy. the first medical consultant and the first medical decision was highly associated with extended professional delays.
Daniel and al published on 2009 a paper on medical malpractice and cancer, they stated that 53% of their patients who accused hoarseness were not evaluated implying that when doctors should have performed a biopsy, they didn’t, which led to patients thinking their laryngectomy was a consequence or a complication of the delay.15
This makes us think that doctors should be more sensitized about laryngeal cancers and the importance of the early diagnosis to prevent radical treatment that might affect the quality of life of patients, a mirrored laryngoscopy is a simple and unharmful examination that can make the practitioner suspect a laryngeal neoplasm, also referring to a laryngologist when not sure about the outcome of the examination is better than leaving the patient on medical treatment.16,17
In our multivariate analysis, multiple factors were identified as related to poor survival prognosis: tumor location, the disease staging, comorbidity index and especially the patient and professional delays. In a study comparing pre-treatment delays between 1992 and 2002 it was found that the delays increased over the years.9 Teppo and al conducted three different studies in 2003, 2008 and 2009, in the three papers the professional delay was strongly related to poor diagnosis, they also stated that the overall survival was related to patients delay, this also was found in smith and al study.5,10,14,16 The comorbidity index impacting the overall survival in laryngeal cancers was studied by multiple authors and was found that patients with a high comorbidity index were unluckily to have a poor prognosis.16,18-21
The diagnosis staging was significantly related to poor diagnosis, as the sooner the diagnosis is mad the sooner the treatment is started and the higher the chances of survival are.6,10,11,14,22
Smoking and drinking as factors influencing the survival in laryngeal carcinoma, were studied but they had no statistically significant impact on the prognosis in our study neither in other studies, these results does’t imply that patients with and without toxic consumption have the same disease progression .10,11
Seeing the results of all these studies, should make us think about ways, us laryngologists, can diminish the professional delay and raise awareness among younger health care givers on the importance of considering chronic dysphonia as a serious condition that could hide behind it a possible cancer diagnosis; make a full laryngeal examination in patients with risk factors who come into consultation, with or without laryngeal symptoms. And more importantly educate the general population, for them to understand the importance of seeking medical advice when presenting symptoms as hoarseness, dysphonia or even Pharyngalgial as it would reduce the patients and professional delays and thus the overall prognosis.10,11,23
Teppo and al stated in their paper that their sample size was small which may affect the generalizability of the results, this is the case for us too.10 still the same results were found in larger samples making these findings of more importance.24-26
Nonetheless, these results must be interpreted with caution and a number of limitations should be borne in mind. A sampling and selection bias and a cultural bias should be considered, as patients don’t always seek professional advice and rising awareness against chronic dysphonia and laryngeal carcinoma should help get a greater sample which would help in the generalization of the findings to the general population.
CONCLUSION
As shown by this study along with many others similar ones; patients and professional delays have a direct impact on the prognosis and overall survival in laryngeal carcinoma. We thus conclude our work with general recommendation aiming to the shortening of these delays; if a special interest is given to educating the general population on the importance of seeking medical advice when presenting chronic dysphonia, and raising awareness, regarding head and neck cancers in general and laryngeal cancer especially, among primary care givers to do laryngeal examination or refer to a specialist.
Funding: No funding sources
Conflict of interest: None declared
Ethical approval: The study was approved by the Institutional Ethics Committee
REFERENCES
- 1. Zhu K, Lin R, Zhang Z, Chen H, Rao X. Impact of prior cancer history on the survival of patients with larynx cancer. BMC Cancer. 2020;20(1):1137.
- 2. Kowalski LP, Torloni H, Fava AS, De Andrade Sobrinho J, Ramos G, Oliveira BV, Curado MP. Lateness of diagnosis of oral and oropharyngeal carcinoma: factors related to the tumour, the patient and health professionals. Eur J Cancer B Oral Oncol. 1994;30B(3):167-73.
- 3. Ildstad DJT, Bigelow ME, Remensnyder JP. A multivariate analysis of determinants of survival for patients with squamous cell carcinoma of the head and neck. Ann Surg. 1989;209(2):237-41.
- 4. Amar A, Chedid HM, Franzi SA, Rapoport A. Retardo diagnóstico e terapêutico em pacientes com câncer da laringe em hospital público de referência. Braz J Otorhinolaryngol. 2010;76(6):700-3.
- 5. H Teppo 1 O-PA. Relative importance of diagnostic delays in different head and neck cancers. Clin Otolaryngol. 2008;33(4):325-30.
- 6. Schutte HW, Heutink F, Wellenstein DJ, van den Broek GB, van den Hoogen FJA, Marres HAM et al. Impact of Time to Diagnosis and Treatment in Head and Neck Cancer: A Systematic Review. Otolaryngol Head Neck Surg. 2020;162(4):446-57.
- 7. Kompelli AR, Li H, Neskey DM. Impact of Delay in Treatment Initiation on Overall Survival in Laryngeal Cancers. Otolaryngol Head Neck Surg. 2019;160(4):651-7.
- 8. Carvalho AL, Schlecht NF, Oliveira BV, Fava AS, Curado MP, Kowalski LP, Franco EL. Predictive Factors for Diagnosis of Advanced-Stage Squamous Cell Carcinoma of the Head and Neck. Arch otolaryngol head neck surg. 2002;128(3):313-8.
- 9. Primdahl H, Nielsen AL, Larsen S, Andersen E, Ipsen M, Lajer C et al. Changes from 1992 to 2002 in the pretreatment delay for patients with squamous cell carcinoma of larynx or pharynx: a Danish nationwide survey from DAHANCA. Acta Oncol. 2006;45(2):156-61.
- 10. Teppo H, Koivunen P, Hyrynkangas K, Alho OP. Diagnostic delays in laryngeal carcinoma: professional diagnostic delay is a strong independent predictor of survival. Head Neck. 2003;25(5):389-94.
- 11. Ramos Innocentini LMA, Teixeira AH, Casemiro LA, Andrade MC, Ferrari TC, Ricz HMA et al. Laryngeal Cancer Attributable Factors and the Influence on Survival Rates: A Single Brazilian Institution Experience. Int Arch Otorhinolaryngol. 2019;23(3):e299-e304.
- 12. Brouha XD, Tromp DM, Hordijk GJ, Winnubst JA, de Leeuw JR. Oral and pharyngeal cancer: analysis of patient delay at different tumor stages. Head Neck. 2005;27(11):939-45.
- 13. Schwartz SR, Cohen SM, Dailey SH, Rosenfeld RM, Deutsch ES, Gillespie MB et al. Clinical practice guideline: hoarseness (dysphonia). Otolaryngol Head Neck Surg. 2009;141(3-2):S1-S31.
- 14. Smith MM, Abrol A, Gardner GM. Assessing delays in laryngeal cancer treatment. Laryngoscope. 2016;126(7):1612-5.
- 15. Daniel D. Lydiatt D, MD, FACS. Medical Malpractice and Cancer of the Larynx. Laryngoscope. 2009;112(3):445-8.
- 16. Teppo H, Alho OP. Comorbidity and diagnostic delay in cancer of the larynx, tongue and pharynx. Oral Oncol. 2009;45(8):692-5.
- 17. Van Harten MC, de Ridder M, Hamming-Vrieze O, Smeele LE, Balm AJ, van den Brekel MW. The association of treatment delay and prognosis in head and neck squamous cell carcinoma (HNSCC) patients in a Dutch comprehensive cancer center. Oral Oncol. 2014;50(4):282-90.
- 18. Wang JR, Habbous S, Espin-Garcia O, Chen D, Huang SH, Simpson C et al. Comorbidity and performance status as independent prognostic factors in patients with head and neck squamous cell carcinoma. Head Neck. 2016;38(5):736-42.
- 19. Gollnitz I, Inhestern J, Wendt TG, Buentzel J, Esser D, Boger D et al. Role of comorbidity on outcome of head and neck cancer: a population-based study in Thuringia, Germany. Cancer Med. 2016;5(11):3260-71.
- 20. Multidisciplinary Larynx Cancer Working G, Mulcahy CF, Mohamed ASR, Kanwar A, Hutcheson KA, Ghosh A et al. Age-adjusted comorbidity and survival in locally advanced laryngeal cancer. Head Neck. 2018;40(9):2060-9.
- 21. Sanabria A, Carvalho AL, Vartanian JG, Magrin J, Ikeda MK, Kowalski LP. Comorbidity Is a Prognostic Factor in Elderly Patients with Head and Neck Cancer. Ann Surg Oncol. 2007;14(4):1449-57.
- 22. Fong PY, Tan SH, Lim DWT, Tan EH, Ng QS, Sommat K et al. Association of clinical factors with survival outcomes in laryngeal squamous cell carcinoma (LSCC). PLoS One. 2019;14(11):e0224665.
- 23. Tiwari V, Yogi V, Ghori HU, Singh OP, Peepre K, Yadav S et al. Identifying the Factors Causing Delayed Presentation of Cancer Patients to a Government Medical College of Central India. J Clin Diagn Res. 2015;9(9):Xc09-xc12.
- 24. Pera AME, Galindo L. Prognostic factors in laryngeal carcinoma. A multifactorial study of 416 cases. Cancer. 1986;58(4):928-34.
- 25. Allison EF, Black M, Feine J. The role of professional diagnostic delays in the prognosis of upper aerodigestive tract carcinoma. Oral Oncol. 1998;34:147-53.
- 26. Walter Habermann M, Berghold A; Trevor TJ, Friedrich G. Carcinoma of the Larynx: Predictors of Diagnostic Delay. Laryngoscope. 2001;111(4 Pt 1):653-6.